RA Capital Nexus Fund, L.P.
Reporting owner on Forms 3, 4 and 5, CIK 1780117.
- In the filer group RA CAPITAL MANAGEMENT, L.P.
RA Capital Nexus Fund, L.P. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-30.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Climb Bio, Inc. CIK 1768446 | director | 1 | 2026-09-30 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Climb Bio, Inc. Common Stock | 2026-09-28 | M exercised | +10,000 | $3.46 | 10,000 | Form 4 |
| Climb Bio, Inc. Common Stock | 2026-09-28 | M exercised | +10,000 | $3 | 20,000 | Form 4 |
| Climb Bio, Inc. Common Stock | 2026-09-28 | M exercised | +10,000 | $7.89 | 30,000 | Form 4 |
| Climb Bio, Inc. Common Stock | 2026-09-28 | M exercised | +40,000 | $1.29 | 70,000 | Form 4 |
| Climb Bio, Inc. Common Stock, holding | 3,837,101 | Form 4 | ||||
| Climb Bio, Inc. Common Stock, holding | 1,226,497 | Form 4 | ||||
| Climb Bio, Inc. Common Stock, holding | 483,679 | Form 4 | ||||
| Climb Bio, Inc. Common Stock, holding | 3,671,766 | Form 4 | ||||
| Climb Bio, Inc. Common Stock, holding | 841,087 | Form 4 | ||||
| Climb Bio, Inc. Stock Option (Right to Buy), derivative | 2026-09-28 | M exercised | -10,000 | $0 | 0 | Form 4 |
| Climb Bio, Inc. Stock Option (Right to Buy), derivative | 2026-09-28 | M exercised | -10,000 | $0 | 0 | Form 4 |
| Climb Bio, Inc. Stock Option (Right to Buy), derivative | 2026-09-28 | M exercised | -10,000 | $0 | 0 | Form 4 |
| Climb Bio, Inc. Stock Option (Right to Buy), derivative | 2026-09-28 | M exercised | -40,000 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001231919-26-001416 | Climb Bio, Inc. | 2026-09-30 |